Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQ97C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,023
Award facts
- Contract value 100% obligated
- $34,022.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $34,022.89 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Stelara 45 mg/0.5 ml syringes. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The pharmaceutical product will be delivered to the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of November 19, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive awards across multiple therapeutic domains. The broader SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products, vaccines, medical devices, and specialty medications to support military healthcare programs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical program continues to be a critical avenue for ensuring pharmaceutical supply chain resilience across the Department of Defense and federal healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQ97C?
SPE2DR26FQ97C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQ97C worth?
The government has obligated $34,023 on SPE2DR26FQ97C.
Is contract SPE2DR26FQ97C an order under another contract?
Yes. SPE2DR26FQ97C is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ97C competed?
The extent of competition for SPE2DR26FQ97C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award